144 related articles for article (PubMed ID: 23836346)
21. Aflibercept--a decoy VEGF receptor.
Ciombor KK; Berlin J
Curr Oncol Rep; 2014 Feb; 16(2):368. PubMed ID: 24445500
[TBL] [Abstract][Full Text] [Related]
22. Aflibercept and its role in the treatment of colorectal cancer--letter.
Sinicrope FA; Williamson EE; Borgeson DD
Clin Cancer Res; 2013 Nov; 19(21):6057. PubMed ID: 24043464
[No Abstract] [Full Text] [Related]
23. Aflibercept: a novel VEGF targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple tumors.
Sharma T; Dhingra R; Singh S; Sharma S; Tomar P; Malhotra M; Bhardwaj TR
Mini Rev Med Chem; 2013 Apr; 13(4):530-40. PubMed ID: 23317499
[TBL] [Abstract][Full Text] [Related]
24. Building a better Trap.
Hood JD; Cheresh DA
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8624-5. PubMed ID: 12861079
[No Abstract] [Full Text] [Related]
25. The value and effectiveness of angiogenesis inhibitors for colorectal cancer.
Venook AP
Clin Adv Hematol Oncol; 2015 Sep; 13(9):561-3. PubMed ID: 26452184
[No Abstract] [Full Text] [Related]
26. [New molecular targeting drugs for metastatic colorectal cancer].
Komatsu Y; Harada K; Fukushima H; Yuki S
Nihon Rinsho; 2014 Jan; 72(1):120-6. PubMed ID: 24597359
[TBL] [Abstract][Full Text] [Related]
27. Ulcerations on abdominal wound scar associated with aflibercept therapy.
Rivas-Tolosa N; Calomarde L; Bancalari B; Guillén C; Sanmartín O
J Dermatol; 2016 Sep; 43(9):1095-6. PubMed ID: 26970060
[No Abstract] [Full Text] [Related]
28. Evaluation of aflibercept in the treatment of metastatic colorectal cancer.
Macarulla T; Sauri T; Tabernero J
Expert Opin Biol Ther; 2014 Oct; 14(10):1493-505. PubMed ID: 25152076
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy with molecular targeting agents for colorectal cancer].
Bando H; Ohtsu A
Nihon Rinsho; 2012 Nov; 70 Suppl 8():468-74. PubMed ID: 23513885
[No Abstract] [Full Text] [Related]
30. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
31. [Sequential inhibition of angiogenesis in metastatic colorectal cancer: activity and efficacy of aflibercept].
Martines C; Cordio S; Bordonaro R
Recenti Prog Med; 2015 May; 106(5):239e-43e. PubMed ID: 25994542
[TBL] [Abstract][Full Text] [Related]
32. Regorafenib (Stivarga) for metastatic colorectal cancer and GIST.
Med Lett Drugs Ther; 2013 Apr; 55(1415):e36. PubMed ID: 23836345
[No Abstract] [Full Text] [Related]
33. Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration.
Stewart MW
Expert Rev Clin Pharmacol; 2013 Mar; 6(2):103-13. PubMed ID: 23473589
[TBL] [Abstract][Full Text] [Related]
34. Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Schachat AP
Am J Ophthalmol; 2013 Jul; 156(1):1-2.e1. PubMed ID: 23791369
[No Abstract] [Full Text] [Related]
35. Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation.
Hermosilla J; Pérez-Robles R; Salmerón-García A; Casares S; Cabeza J; Bones J; Navas N
Sci Rep; 2020 Feb; 10(1):2675. PubMed ID: 32060315
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms and targeting of colorectal cancer.
Vanhoefer U
Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
[TBL] [Abstract][Full Text] [Related]
37. [Some problems facing the molecular targeting therapy for colorectal cancer].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):321-3. PubMed ID: 19799077
[No Abstract] [Full Text] [Related]
38. Aflibercept (eylea) for age-related macular degeneration.
Med Lett Drugs Ther; 2012 Feb; 54(1383):9-10. PubMed ID: 22354219
[No Abstract] [Full Text] [Related]
39. [Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012].
Pauleikhoff D; Bertram B; Holz FG; Kirchhof B; Bartz-Schmidt U; Bornfeld N; Bresgen M; Eter N; Friedrichs W; Heimann H; Helbig H; Hörauf H; Kampik A; Lemmen KD; Roider J; Ziemssen F
Klin Monbl Augenheilkd; 2013 Feb; 230(2):170-7. PubMed ID: 23430681
[No Abstract] [Full Text] [Related]
40. Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients.
Lu CS; Lin JK; Chen WS; Lin TC; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Lin HH; Teng HW
Oncotarget; 2017 May; 8(22):36707-36715. PubMed ID: 27888621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
